“It all started in the 1950s with the famous mathematician Alan Turing, who asked the question – can machines think?” – Pieter Peeters, Janssen Research & Development.
In a recent interview with Technology Networks, Pieter Peeters, Leader of High Dimensional Biology and Discovery Data Sciences Group at Janssen Research & Development, discusses the evolution of artificial intelligence (AI), and how it can be used to discover, develop and test new drugs.
“Artificial intelligence is a discipline in computer science that deals with building smart computer algorithms that mimic the things we typically associate with the human brain,” explains Peeters.
“Personally, I don’t like the term artificial intelligence, because I think we still have a way to go before machines can be said to have real intelligence, but we are heading in that direction.”
So, what has changed since the 1950s, and how is AI now integrated into many industries, including drug discovery? Peeters explains that AI’s ability to influence these industries, is due to developments in three main areas – data volume and accessibility, hardware, and the algorithms themselves.
Read the full article in Technology Networks website